PRNAF (Alterity Therapeutics) Tax Rate %: 5.19% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PRNAF Alterity Therapeutics Ltd PRNAF
34 GF Score
Price $0.40
! 1 Warning Sign
View Full Analysis

What is Alterity Therapeutics Tax Rate %?

Alterity Therapeutics PRNAF 34 Tax Rate % is 5.19% as of Jun. 2026. GuruFocus rates PRNAF with a GF Score™ of 34/100. The stock has 1 warning sign investors should review.

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Alterity Therapeutics's Tax Expense for the six months ended in Jun. 2026 was $-0.53 Mil. Alterity Therapeutics's Pre-Tax Income for the six months ended in Jun. 2026 was $-10.21 Mil. Therefore, Alterity Therapeutics's Tax Rate % for the quarter that ended in Jun. 2026 was 5.19%.

Alterity Therapeutics Tax Rate % Related Terms

Alterity Therapeutics Tax Rate % Historical Data

* Premium members only.

The historical data trend for Alterity Therapeutics's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alterity Therapeutics Tax Rate % Chart

Alterity Therapeutics Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Tax Rate %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.66 13.00 -0.24 -0.56 -0.48

Alterity Therapeutics Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.11 18.29 43.08 22.19 5.19
PRNAF
34GF Score
Alterity Therapeutics Ltd PRNAF
Tax Rate % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alterity Therapeutics Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Alterity Therapeutics's Tax Rate % for the fiscal year that ended in Jun. 2026 is calculated as

Tax Rate %=Tax Expense (A: Jun. 2026 )/Pre-Tax Income (A: Jun. 2026 )
=-2.3693201292923/-18.226339989411
=13.00 %

Alterity Therapeutics's Tax Rate % for the quarter that ended in Jun. 2026 is calculated as

Tax Rate %=Tax Expense (Q: Jun. 2026 )/Pre-Tax Income (Q: Jun. 2026 )
=-0.53017432443595/-10.214727392035
=5.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Rate % →
What does a Tax Rate % of 5.19% mean?
Alterity Therapeutics (PRNAF) has a Tax Rate % of 5.19% as of Jun. 2026.
Is Alterity Therapeutics' Tax Rate % too high?
Alterity Therapeutics' current Tax Rate % is 5.19%. Overall, Alterity Therapeutics has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Alterity Therapeutics' Tax Rate % compare to VRTX and REGN?
Alterity Therapeutics' Tax Rate % of 5.19% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Rate % for a Biotechnology company?
A good Tax Rate % depends on the Biotechnology industry context. However, Tax Rate % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Rate % mean?
A high Tax Rate % can signal that a stock is expensive relative to its fundamentals. Alterity Therapeutics's current Tax Rate % is 5.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alterity Therapeutics stock overvalued right now?
Alterity Therapeutics (PRNAF) has a current Tax Rate % of 5.19%. The current Tax Rate % is 5.19%. Alterity Therapeutics' overall GF Score™ is 34/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Rate % calculated?
Tax Rate % is calculated from a company's financial statements. For Alterity Therapeutics (PRNAF), the current Tax Rate % is 5.19% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alterity Therapeutics Business Description

Address 350 Collins Street, Suite 4, Level 14, Melbourne, VIC, AUS, 3000
Alterity Therapeutics Ltd is a clinical-stage biotechnology company focused on neurodegenerative diseases and the creation of a chemical library of proprietary molecules. Its research and clinical development efforts are focused on Parkinson's disease and related disorders, where it is identifying and developing novel compounds that address the underlying pathology of these disorders by binding and redistributing excess labile iron, reducing alpha-synuclein aggregation, and rescuing neurons in the brain. Its pipeline programs are ATH434-201, ATH434-202, bioMUSE, ATH434, and Drug Discovery. The Group operated in one segment, research and development into Parkinsonian and other neurodegenerative disorders.
34GF Score

Get the complete analysis for PRNAF

Tax Rate % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.40
Price